MV Capital Management Inc. Acquires New Position in Abbott Laboratories $ABT
MarketBeat
MV Capital Management Inc. bought a new position in Abbott Laboratories (NYSE:ABT - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 281,969 shares of the healthcare product maker's stock, valued at approximately $35,328,000. A
NYSE:ABT